PharmAla Biotech Logo 800 x 422.png
Mindset Pharma and PharmAla Biotech Enter into Exclusive Sales Agreement
November 16, 2022 07:30 ET | PharmAla Biotech
VANCOUVER, British Columbia, Nov. 16, 2022 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA), a biotechnology company focused on the research, development, and manufacturing...
PharmAla Biotech Logo 800 x 422.png
PharmAla Submits Pre-IND Dossier for Novel MDMA Analog to FDA
November 02, 2022 09:00 ET | PharmAla Biotech
VANCOUVER, British Columbia, Nov. 02, 2022 (GLOBE NEWSWIRE) -- PharmAla Biotech (CSE:MDMA) is pleased to announce that it has submitted its pre-IND data meeting package to the US Food and Drug...
The clinical trials software market is projected to be growing at a CAGR of 14%, claims Roots Analysis
June 08, 2022 08:13 ET | Roots Analysis
London, June 08, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Clinical Trials Software Market, 2022-2035” report to its list of offerings. Excessive capital expenditure...
Avocados That Stay Fresh for Up to Twice as Long, Now Available in Europe Thanks to Save Foods and Galilee Export
February 23, 2022 08:55 ET | Save Foods Inc
Galilee Export, the Second Largest Exporter of Fresh Produce in Israel, to Use Save Foods' Eco Crop Treatment on All Avocados, Mangos to Follow Miami, FL, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Save...
AB Science annonce la validation de son plan de gestion des risques par l'ANSM en vue de la reprise des inclusions en France
July 12, 2021 02:00 ET | AB Science
                                                                                                                                                                                           COMMUNIQUE DE...
AB Science announces the validation of its Risk Management Plan by the French National Agency (ANSM) in order to restart patient enrollment in France
July 12, 2021 02:00 ET | AB Science
Isracann BioSciences Logo RGB@4x-100 LG.jpg
Isracann Increases Focus on EU Demand
May 14, 2020 00:05 ET | Isracann Biosciences Inc.
VANCOUVER, British Columbia, May 14, 2020 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on...
March 28, 2020 06:57 ET | Altasciences Company Inc.
魁北克拉瓦尔, March 28, 2020 (GLOBE NEWSWIRE) --...
Altasciences Completes Phase I Study on Gimsilumab for ARDS in COVID-19
March 27, 2020 13:48 ET | Altasciences Company Inc.
LAVAL, Quebec, March 27, 2020 (GLOBE NEWSWIRE) -- Altasciences has completed a Phase I study for the development of gimsilumab, a fully human monoclonal antibody that targets granulocyte-macrophage...
WPD Pharmaceuticals Provides 2019 Corporate Year End Review
January 08, 2020 03:05 ET | WPD Pharmaceuticals
VANCOUVER, British Columbia, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Westcot Ventures Corp. (CSE: WBIO) (the “Company”), and its wholly-owned subsidiary WPD Pharmaceuticals sp. z.o.o (“WPD”), a clinical...